Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK

A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches

NCT02160067 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence and Adhesion Comparison of Buprenorphine Patches

NCT02268422 ·Status: COMPLETED ·Phase: PHASE1

Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain

NCT00490919 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

NCT00315874 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.

NCT00313833 ·Status: COMPLETED ·Phase: PHASE3

Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch

NCT03785613 ·Status: COMPLETED ·Phase: PHASE1

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

NCT00531427 ·Status: COMPLETED ·Phase: PHASE3

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

NCT00218101 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

NCT00313014 ·Status: TERMINATED ·Phase: PHASE3

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

NCT00315835 ·Status: COMPLETED ·Phase: PHASE2

Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase

NCT01141283 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users

NCT02413281 ·Status: COMPLETED ·Phase: PHASE1

Multicenter Clinical Trial of Buprenorphine - 3

NCT00000207 ·Status: COMPLETED ·Phase: PHASE3

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

NCT05988710 ·Status: RECRUITING ·Phase: PHASE4

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

NCT00315458 ·Status: TERMINATED ·Phase: PHASE3

Buprenorphine Pharmacology Related to Addiction Treatment - 21

NCT00000239 ·Status: COMPLETED ·Phase: PHASE2

Buprenorphine Combination Tablet Feasibility - 1

NCT00000298 ·Status: COMPLETED ·Phase: PHASE2

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

NCT01259102 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain

NCT01256450 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.

NCT00315445 ·Status: COMPLETED ·Phase: PHASE3

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

NCT00813488 ·Status: COMPLETED ·Phase: PHASE3

True Functional Restoration and Analgesia in Non-Radicular Low Back Pain

NCT05419297 ·Status: UNKNOWN ·Phase: PHASE4

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

NCT02310581 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

NCT00000302 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Buprenorphine/Naloxone

NCT02882412 ·Status: UNKNOWN